Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate AngioDynamics, Inc. before investing.

In this article, we go over a few key elements for understanding AngioDynamics, Inc.’s stock price such as:

• AngioDynamics, Inc.’s current stock price and volume
• Why AngioDynamics, Inc.’s stock price changed recently
• Upgrades and downgrades for ANGO from analysts
• ANGO’s stock price momentum as measured by its relative strength

About AngioDynamics, Inc. (ANGO)

Before we jump into AngioDynamics, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company’s thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers’ off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Want to learn more about AngioDynamics, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about AngioDynamics, Inc..

AngioDynamics, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, AngioDynamics, Inc.’s stock price was $14.790.

AngioDynamics, Inc. is up 0.14% from its previous closing price of $14.770.

During the last market session, AngioDynamics, Inc.’s stock traded between $14.590 and $14.930. Currently, there are approximately 41.70 million shares outstanding for AngioDynamics, Inc..

AngioDynamics, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

AngioDynamics, Inc. Stock Price History

AngioDynamics, Inc.’s (ANGO) price is currently up 13.68% so far this month.

During the month of July, AngioDynamics, Inc.’s stock price has reached a high of $15.200 and a low of $12.310.

Over the last year, AngioDynamics, Inc. has hit prices as high as $15.195 and as low as $8.360. Year to date, AngioDynamics, Inc.’s stock is up 15.19%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused AngioDynamics, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there was 1 analyst who downgraded AngioDynamics, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate AngioDynamics, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on AngioDynamics, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

AngioDynamics, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about AngioDynamics, Inc. (ANGO) by visiting AAII Stock Evaluator.

Relative Price Strength of AngioDynamics, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, AngioDynamics, Inc. has a weighted four-quarter relative price strength of 14.91%, which translates to a Momentum Score of 88 and is considered to be Very Strong.

Want to learn more about how AngioDynamics, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

AngioDynamics, Inc. Stock Price: Bottom Line

As of July 31, 2026, AngioDynamics, Inc.’s stock price is $14.790, which is up 0.14% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like AngioDynamics, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.